How Paper And Electronic Source Data Meet ALCOA-C Principles
By Shannon Roznoski, CCDM, CCRP, Director of Product Management
According to the Food and Drug Administration (FDA), data should meet certain fundamental elements of quality. Whether they’re recorded on paper or electronically, source data should follow ALCOA-C, an acronym used in clinical research for:
If these best practices for source documentation aren’t followed, there is no valid evidence the test article is safe and effective.
What does each element of ALCOA-C mean, and how are the principals implemented differently for data originally collected on paper versus first recorded electronically?
VIEW THE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader X
Subscribe to Clinical Leader